Results 121 to 130 of about 85,967 (221)

异基因造血干细胞移植后血清可溶性白介素-2受体对急性移植物抗宿主病的预测研究

open access: yesZhongguo shiyan zhenduanxue, 2018
目的探究异基因造血干细胞移植后血清可溶性白介素-2受体(soluble interleukin-2receptor,sIL-2R)对急性移植物抗宿主病(acute graft-versus-host disease,aGVHD)的预测价值。方法回顾分析我院接受异基因造血干细胞移植患者12例,其中6例发生aGVHD,6例未发生aGVHD。移植前、移植后+14天、+28天、+42天、+60天、+90天通过ELISA试剂盒检测患者外周血sIL-2R水平,并分析其与aGVHD发生的相关性。结果本组患者血清sIL-
刘文静   +7 more
doaj  

不同肝病者外周血 sIL-2R 的检测及意义

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1998
目的:探讨几种肝病患者外周血可溶性白细胞介素 2 受体 ( sIL-2R) 水平状态及其临床意义。方法:采用双 抗体夹心 ELISA 法检测慢性乙型肝炎、 肝硬化和原发性肝癌患者 (共 70 例)与健康人 ( 22 例)的外周血 sIL-2R 水平, 并 比较原发性肝癌 ( 15 例)手术前后 sIL-2R 水平的变化。结果:与对照组相比, 慢性乙型肝炎、 肝硬化和原发性肝癌患者 的 sIL-2R 水平明显增高;肝癌术后 sIL-2R 水平明显下降;sIL-2R 水平与肝癌临床分期相关。结论 ...
doaj  

Clinical Correlates and Prognostic Significance of IL-8, sIL-2R, and Immunoglobulin-Free Light Chain Levels in Patients with Myelofibrosis

open access: yesOncology Research and Treatment, 2017
M. Barabanshikova   +7 more
semanticscholar   +1 more source

Soluble Interleukin-2 Receptors (sIL-2R) in Ovarian Cancer Patients: Changes in sIL-2R after Surgery as a Prognostic Factor?

open access: yesThe International Journal of Biological Markers, 1998
G. Gebauer   +3 more
openaire   +1 more source

Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency

open access: yesEuropean Respiratory Journal, 2015
A. Verwoerd   +5 more
semanticscholar   +1 more source

Value of serum cytokine biomarkers TNF-α, IL-4, sIL-2R and IFN-γ for use in monitoring bacterial load and anti-tuberculosis treatment progress. [PDF]

open access: yesCytokine X, 2020
Nie W   +13 more
europepmc   +1 more source

A novel scoring system based on sIL-2R for predicting IVIG resistance in Chinese children with KD. [PDF]

open access: yesPediatr Rheumatol Online J
Zeng YY   +7 more
europepmc   +1 more source

Diagnostic Value of sLR11 and sIL-2R in the Cerebrospinal Fluid for Malignant Central Nervous System Lymphoma. [PDF]

open access: yesIntern Med
Shimizu N   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy